Author: Brownson Norby Source: http://www.brownsonnorby.com/blog/fda-and-cbd/ Earlier this month, on April 9, 2018, FDA published a notice requesting comments from the public on the scheduling of cannabis-related substances (“Cannabis Plant and Resin; Extracts...
Authored By: Rod Kight 13 April 2018 The FDA is taking public comments on cannabinoids until April 23. It seeks information on abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use. I strongly...
Adam Detsky and Carlos Enrique Provencio of Wilson Elser write…… In November 2011, the governors of Washington and Rhode Island[1] filed a petition with the U.S. Drug Enforcement Agency (DEA) asking that marijuana be reclassified as a Schedule II drug. Nearly...